VIA Pharmaceuticals, Inc. — Form D/A
VIA Pharmaceuticals, Inc. of San Francisco, CA, a company, filed a Form D amendment with the SEC on 2010-11-17. The offering totals $12.0M, of which $3.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-11-17
- Form: D/A
- Accession: 0001209191-10-055483
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $12.0M
- Amount sold: $3.2M
- Remaining: $8.8M
- Investors: 2
- Date of first sale: 2010-03-29
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-57801
Issuer
- Name: VIA Pharmaceuticals, Inc.
- CIK: 0001003929
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 750 Battery Street, San Francisco, CA, 94111
- Phone: 415-283-2200
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Mark NK Bagnall | Director | San Francisco, CA |
| Lawrence K Cohen | Director | Menlo Park, CA |
| Fred B Craves | Director | San Francisco, CA |
| Douglass B Given | Director | San Francisco, CA |
| David T Howard | Director | San Francisco, CA |
| John R Larson | Director | San Francisco, CA |
| Lawrence K Cohen | Executive Officer | Menlo Park, CA |
| Rebecca A Taub | Executive Officer | San Francisco, CA |
| Karen S Wright | Executive Officer | San Francisco, CA |
| James G Stewart | Executive Officer | New York, NY |
Other filings by this issuer (1)
More